New hope for Alzheimer's patients struggling with sleepless nights
NCT ID NCT05924425
First seen Apr 29, 2026 · Last updated Jun 15, 2026 · Updated 3 times
Summary
This study tests whether daridorexant, a sleep aid, can safely improve total sleep time in 62 adults aged 60-85 with mild cognitive impairment or mild-to-moderate Alzheimer's disease who also have chronic insomnia. Participants will have their sleep measured in a lab. The goal is to see if the drug helps them sleep longer and wake less during the night.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital, Montpellier
RECRUITINGMontpellier, France
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.